Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CyberArk Introduces Peer-Based Framework for Evaluating and Maturing Identity Security Strategies ... | March 28, 2023
By Cecilia Butini Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary endpoint during an interim analysis. The drug is shown to significantly reduce... | March 27, 2023
TME PHARMA ANNOUNCES 83% OF GLIOBLASTOMA PATIENTS STILL ALIVE AFTER 12 MONTHS ON STUDY IN GLORIA EXPANSION ARM EVALUATING NOX-A12 IN COMBINATION WITH... | March 27, 2023
By Chris Wack Protagonist Therapeutics Inc. said Tuesday it saw positive topline results from its collaboration with Janssen Biotech Inc. in a Phase 2b clinical trial evaluating the oral... | March 7, 2023
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million... | March 3, 2023